ArticleCureus2025
Intrauterine Herpes Simplex Virus Infection: Insights Into a Silent Threat.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a rare case of congenital herpes simplex virus type 2 (HSV-2) infection in a neonate born to a mother with no clinical evidence of genital HSV infection either before or during pregnancy. Routine prenatal ultrasound assessments in the first two trimesters were unremarkable, and infectious disease screening results were negative. The pregnancy, however, was complicated by premature rupture of membranes (PROM) at 24 weeks of gestation. An ultrasound at that time revealed severe fetal malformations, including brain abnormalities and organomegaly. At 31 weeks, an emergency cesarean section was performed, delivering a female baby with profound physical abnormalities, including extensive skin erosions and severe neurological impairment. On the fourth day of life, grouped vesicles emerged, leading to the initiation of intravenous acyclovir therapy. Polymerase chain reaction testing of skin swabs confirmed HSV-2 infection. Despite antiviral treatment, the neonate's condition rapidly deteriorated, culminating in death on the fifth day of life. This case highlights the diagnostic challenges of intrauterine HSV infection in the absence of maternal symptoms. It emphasizes the importance of considering HSV infection in the differential diagnosis when PROM is accompanied by significant fetal malformations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.